The Nixon Visions Foundation and The Foundation Fighting Blindness invites you to join a free, in-person workshop for those affected by PRPH2 and associated retinal diseases. Click for details.
Determining the genetic causes of PRPH2-related retinal diseases, understanding why symptoms of vision loss vary widely, and testing a new treatment approach, are the targets of research grants awarded in 2025 by the Foundation Fighting Blindness.
The Foundation Fighting Blindness, in collaboration with the Nixon Visions Foundation, has announced the recipients of the first awards in the PRPH2 and Associated Retinal Diseases (PARD) Program. These grants mark a significant milestone in advancing research into retinal diseases caused by mutations in the PRPH2 gene.
The San Diego Foundation held its annual Community Scholarship Celebration for hundreds of students receiving scholarships for the 2023-24 academic year. Five students were honored for receiving college scholarships sponsored by the Nixon Visions Foundation.
People with blinding retinal diseases caused by PRPH2 gene mutations gathered in La Jolla CA to learn what is known about their condition and about the latest advances in research to understand and develop treatments and preventions.
Nixon Visions fielded a team to walk and raise funds for the Foundation Fighting Blindness on April 8. Our team enjoyed a fun event and celebration on a sunny morning in New York’s Central Park.
March 29, 2023 – The urgent mission of the Foundation Fighting Blindness is to drive the research that leads to preventions, treatments, and cures for degenerative retinal diseases, including those caused by mutations in the PRPH2 gene.
